ERISEris Lifesciences Limited
Convert to ideaPharmaceuticals & Biotechnology · Pharmaceuticals · India Ratings: AA (Stable)
The verdict combines business quality, price and timing. Sign in free to see it.
Sign in freeUp 0.1 this quarter.
Momentum from moving averages, Supertrend and RSI.
5 forensic issues found. Sign in to see which.
Valuation Metrics
Q2 FY2027Intrinsic value, Graham number and DCF against today's price
5 found · risk elevated
Quality, growth, balance sheet and earnings quality behind the score
ⓘ Based on fundamental & forensic analysis. Always verify against official filings and consult a financial advisor.
Financial Metrics
Comparing Q2 FY2027 vs Q2 FY2026
| Quarter | Revenue | Net Profit | OPM | NPM | EPS | Int. Cover |
|---|---|---|---|---|---|---|
| Q2 FY2027 | ₹892 Cr | ₹187 Cr | 26.44% | 20.97% | ₹13.26 | 4.4x |
| Q1 FY2027 | ₹873 Cr | ₹143 Cr | 25.67% | 16.41% | ₹10.28 | 4.9x |
| Q4 FY2026 | ₹757 Cr | ₹279 Cr | 26.96% | 36.89% | ₹20.60 | 4.5x |
| Q3 FY2026 | ₹807 Cr | ₹109 Cr | 26.17% | 13.48% | ₹7.32 | 4.0x |
| Q2 FY2026 | ₹792 Cr | ₹134 Cr | 27.65% | 16.97% | ₹8.82 | 4.5x |
| Q1 FY2026 | ₹773 Cr | ₹125 Cr | 26.68% | 16.18% | ₹8.66 | 4.3x |
Momentum score, 1-year chart, moving averages, support and resistance.
Turnaround stage, and how each measure moved over 3 years against the company's own range.
Order wins, capex, pledges, rating actions and every material filing.
Management guidance, Q&A highlights and whether they delivered what they said.
The earnings call read across investor dimensions.
Promoter, FII and mutual fund holding, and what changed this quarter.
Similar-size peers in Pharmaceuticals
Compare with peers →Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally. The company offers various branded formulations in various therapeutic areas, such as antidiabetes, cardiovascular, nutrition, dermatology, neuroscience, gynecology, nephrology, and oncology, as well as central nervous system, women's health, and vitamins/minerals/nutrients. It also provides patient care services, including ambulatory blood pressure measurement, ambulatory electrocardiogram measurement, continuous glucose monitoring system, sleep study, and anti-natal care solutions. It offers its products through wholesale drug distributors, stockists, retail and e-commerce pharmacies. Eris Lifesciences Limited was incorporated in 2007 and is headquartered in Ahmedabad, India.
Note: This comprehensive analysis combines technical data, fundamental data, and investment thesis. Always do your own research and consider your personal risk tolerance before investing.